X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse AANJANEYA LIFECARE with ACTAVIS INC. - US - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 DR. DATSONS LABS   ACTAVIS
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
ACTAVIS
Dec-14
DR. DATSONS LABS/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs12617,418-   
Low Rs3110,625-   
Sales per share (Unadj.) Rs133.03,136.6-  
Earnings per share (Unadj.) Rs0.2-391.4-  
Cash flow per share (Unadj.) Rs6.6287.8-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs128.86,803.1-  
Shares outstanding (eoy) m31.66265.90-   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.64.5 13.2%   
Avg P/E ratio x516.1-35.8 -1,440.8%  
P/CF ratio (eoy) x11.848.7 24.3%  
Price / Book Value ratio x0.62.1 29.5%  
Dividend payout %00-   
Avg Mkt Cap Rs m2,4773,728,306 0.1%   
No. of employees `000NA21.6 0.0%   
Total wages/salary Rs m560-   
Avg. sales/employee Rs ThNM38,611.5-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM-4,818.3-  
INCOME DATA
Net Sales Rs m4,211834,009 0.5%  
Other income Rs m79-2,082 -3.8%   
Total revenues Rs m4,289831,927 0.5%   
Gross profit Rs m569107,140 0.5%  
Depreciation Rs m204180,593 0.1%   
Interest Rs m43026,306 1.6%   
Profit before tax Rs m13-101,841 -0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m0-7,470 0.0%   
Tax Rs m6-5,236 -0.1%   
Profit after tax Rs m5-104,076 -0.0%  
Gross profit margin %13.512.8 105.1%  
Effective tax rate %48.05.1 934.3%   
Net profit margin %0.1-12.5 -0.9%  
BALANCE SHEET DATA
Current assets Rs m6,852439,416 1.6%   
Current liabilities Rs m6,711320,463 2.1%   
Net working cap to sales %3.314.3 23.5%  
Current ratio x1.01.4 74.5%  
Inventory Days Days16158 277.2%  
Debtors Days Days31866 480.5%  
Net fixed assets Rs m3,673101,841 3.6%   
Share capital Rs m3170-   
"Free" reserves Rs m3,7610-   
Net worth Rs m4,0781,808,934 0.2%   
Long term debt Rs m1,671947,917 0.2%   
Total assets Rs m12,6333,315,181 0.4%  
Interest coverage x1.0-2.9 -35.9%   
Debt to equity ratio x0.40.5 78.2%  
Sales to assets ratio x0.30.3 132.5%   
Return on assets %3.4-2.3 -146.8%  
Return on equity %0.1-5.8 -2.0%  
Return on capital %7.7-3.0 -254.9%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Net fx Rs m3570-   
CASH FLOW
From Operations Rs m1,345143,216 0.9%  
From Investments Rs m-2,256-342,913 0.7%  
From Financial Activity Rs m-1,200192,667 -0.6%  
Net Cashflow Rs m-2,111-7,030 30.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 63.85 Rs / USD

Compare DR. DATSONS LABS With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare DR. DATSONS LABS With: PFIZER  J.B.CHEMICALS  MERCK LTD  NATCO PHARMA  STERLING BIOTECH  



Today's Market

Of Global Markets Hitting Record Highs and Top Stocks in Action During the Week(RoundUp)

Global stock markets ended the week on a positive note. Benchmark indices in US grew by 1% during the week. The Down Jones Industrial Average topped the 26,000.

Related Views On News

Apollo Micro Systems Ltd. (IPO)

Jan 9, 2018

Should you subscribe to the IPO of Apollo Micro Systems Ltd?

Khadim India Ltd. (IPO)

Oct 31, 2017

Should you subscribe to the IPO of Khadim India Ltd?

Mahindra Logistics Ltd. (IPO)

Oct 28, 2017

Should you subscribe to the IPO of Mahindra Logistics Ltd?

Godrej Agrovet Ltd. (IPO)

Oct 4, 2017

Should you subscribe to the IPO of Godrej Agrovet Limited?

Matrimony.com (IPO)

Sep 11, 2017

Should you subscribe to the IPO of Matrimony.com?

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS - ALKEM LABORATORIES COMPARISON

COMPARE DR. DATSONS LABS WITH

MARKET STATS